Davis R J, Johnson G L, Kelleher D J, Anderson J K, Mole J E, Czech M P
J Biol Chem. 1986 Jul 5;261(19):9034-41.
Addition of tumor-promoting phorbol diesters to [32P]phosphate-labeled A431 human epidermoid carcinoma cells caused an increase in the phosphorylation state of the transferrin receptor. The A431 cell transferrin receptor was also found to be a substrate for protein kinase C in vitro. Tryptic phosphopeptide mapping of the transferrin receptor resolved the same two phosphopeptides (X and Y) after either protein kinase C phosphorylation in vitro or treatment of labeled A431 cells with phorbol diesters. [32P]Phosphoserine was the only labeled phosphoamino acid detected. Phosphopeptide X was shown to be an incomplete tryptic digestion product which could be further digested with trypsin to generate the limit tryptic phosphopeptide (Y). Radiosequence analysis of [32P]phosphopeptide Y demonstrated that the [32P]phosphoserine was the second residue from amino terminus of the peptide. This receptor phosphopeptide was found to co-migrate with the synthetic peptide Phe-Ser(P)-Leu-Ala-Arg (where Ser(P) is phosphoserine) during reverse-phase high pressure liquid chromatography and two-dimensional thin layer electrophoresis and chromatography. The peptide Phe-Ser(P)-Leu-Ala-Arg is an expected tryptic fragment of the cytoplasmic domain of the transferrin receptor corresponding to residues 23-27. We conclude that the major site of protein kinase C phosphorylation of the transferrin receptor in vivo and in vitro is serine 24. This phosphorylation site is located within the intracellular domain of the transferrin receptor, 38 residues away from the predicted transmembrane domain.
向用[32P]磷酸盐标记的A431人表皮样癌细胞中添加促肿瘤佛波酯会导致转铁蛋白受体的磷酸化状态增加。还发现A431细胞转铁蛋白受体在体外是蛋白激酶C的底物。转铁蛋白受体的胰蛋白酶磷酸肽图谱显示,在体外进行蛋白激酶C磷酸化或用佛波酯处理标记的A431细胞后,可分辨出相同的两种磷酸肽(X和Y)。检测到的唯一标记磷酸氨基酸是[32P]磷酸丝氨酸。磷酸肽X被证明是一种不完全的胰蛋白酶消化产物,可用胰蛋白酶进一步消化以生成极限胰蛋白酶磷酸肽(Y)。[32P]磷酸肽Y的放射性序列分析表明,[32P]磷酸丝氨酸是该肽氨基末端的第二个残基。在反相高压液相色谱以及二维薄层电泳和色谱分析过程中,发现该受体磷酸肽与合成肽Phe-Ser(P)-Leu-Ala-Arg(其中Ser(P)是磷酸丝氨酸)共迁移。肽Phe-Ser(P)-Leu-Ala-Arg是转铁蛋白受体胞质结构域对应于23-27位残基的预期胰蛋白酶片段。我们得出结论,转铁蛋白受体在体内和体外进行蛋白激酶C磷酸化的主要位点是丝氨酸24。该磷酸化位点位于转铁蛋白受体的细胞内结构域内,距离预测的跨膜结构域38个残基。